+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "AI In Life Sciences"

From
Artificial Intelligence (AI) in Life Sciences Market - Product Thumbnail Image

Artificial Intelligence (AI) in Life Sciences Market

  • Report
  • August 2024
  • 100 Pages
  • Global
From
From
Artificial Intelligence in Life Sciences Market Report 2025 - Product Thumbnail Image

Artificial Intelligence in Life Sciences Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
Life Science Analytics Market Report 2025 - Product Thumbnail Image

Life Science Analytics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
AI in Life Science Analytics Market Report 2025 - Product Thumbnail Image

AI in Life Science Analytics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
UAE Life Science Tools Market, By Region, Competition, Forecast & Opportunities, 2020-2030F - Product Thumbnail Image

UAE Life Science Tools Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • February 2025
  • 85 Pages
  • United Arab Emirates United Arab Emirates
From
From
Loading Indicator

The AI in Life Sciences market pertains to the application of artificial intelligence technologies within the field of biotechnology to advance research, drug discovery, personalized medicine, and diagnostic processes. This interdisciplinary collaboration bridges computational methods, such as machine learning, natural language processing, and image recognition, with molecular biology, genomics, and biopharmaceutical development. AI-driven tools are employed for analyzing complex biological data, predicting molecular behavior, and accelerating the development of new therapies by identifying potential drug candidates more efficiently than traditional methods. The use of AI in life sciences also extends to enhancing clinical trial design, patient monitoring, and improving the accuracy of diagnostics through advanced pattern recognition in medical imaging. The integration of AI into biotechnology is reshaping the landscape of life science research by enabling the handling and interpretation of the vast amounts of data generated in modern biological experiments and enhancing the precision of biomedical applications. Within this market, several players have emerged as front-runners. Companies like Deep Genomics leverage AI for genomic medicine, while Recursion Pharmaceuticals uses it for drug discovery. Insitro and Atomwise apply AI to identify novel drug candidates, and PathAI focuses on improving diagnostic accuracy in pathology. Other notable companies in the space include BenevolentAI, which applies AI to understand diseases and discover potential drugs, and Verge Genomics, which uses AI to analyze genetic data for neurodegenerative diseases. Show Less Read more